This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slipped 7.1% to $1.84 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.6% to 18,350.19 and Dow Jones Industrial Average falling 1.5% to 43,191.24.
Inovio Pharmaceuticals Inc. closed 87.5% short of its 52-week high of $14.75, which the company achieved on April 1st.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 1.4% to $167.28, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 0.68% to $26.25.
Trading volume totaled 575,422, compared to the 50-day average of 1.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 03, 2025 16:34 ET (21:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.